Company Analysis

Phibro Animal Health Corporation (PAHC)

Nasdaq: PAHC · Pharmaceutical Preparations · Teaneck, NJ · filing with the SEC since 1998
Grade6.4
◀ Past 8.0● Present 6.4▶ Future 4.7

Filings

243 filings since 2017 beside 206 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-Q Quarterly report for the quarter ending Dec 31, 2026Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by Feb 9, 2027
10-K Annual report for the fiscal year ending Jun 30, 2027Large accelerated filers have 60 days after the fiscal year ends. by Aug 29, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Sep 18, 2026.

Filings a yearinsider forms included
2822212332365679
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Jun 26, 2026.
Insider forms 206

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 4, 2026 8-K items 2.02, 5.07, 9.01 Results released; Shareholder vote · Current report Nov 3, 2026
Nov 4, 2026 10-Q Quarterly report Sep 30, 2026
Nov 3, 2026 8-K items 8.01, 9.01 Other event · Current report
Oct 19, 2026 SCHEDULE 13G/A Large holder update, amended
Sep 18, 2026 ARS Annual report to shareholders Jun 30, 2026
Sep 18, 2026 DEFA14A Extra proxy material
Sep 18, 2026 DEF 14A Proxy statement Nov 3, 2026
Aug 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 26, 2026 10-K Annual report Jun 30, 2026
Aug 6, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 30, 2026 SCHEDULE 13G Large holder notice
Jul 28, 2026 8-K items 8.01, 9.01 Other event · Current report
Jun 26, 2026 8-K item 5.02 Officer or director change · Current report Jun 25, 2026
May 22, 2026 SCHEDULE 13D/A Activist holder update, amended
May 14, 2026 SCHEDULE 13G/A Large holder update, amended
May 6, 2026 8-K items 2.02, 9.01 Results released · Current report
May 6, 2026 10-Q Quarterly report Mar 31, 2026
May 5, 2026 8-K items 8.01, 9.01 Other event · Current report
Apr 30, 2026 SCHEDULE 13G Large holder notice
Apr 30, 2026 8-K items 1.01, 2.03, 9.01 Major agreement signed; New debt or obligation taken on · Current report Apr 28, 2026
Apr 27, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Apr 23, 2026 SCHEDULE 13D/A Activist holder update, amended
Apr 14, 2026 8-K item 5.02 Officer or director change · Current report Apr 13, 2026
Apr 7, 2026 SCHEDULE 13G Large holder notice
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 11, 2026 SCHEDULE 13G Large holder notice
Feb 4, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 4, 2026 10-Q Quarterly report Dec 31, 2025
Feb 3, 2026 8-K items 8.01, 9.01 Other event · Current report
Dec 18, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Dec 16, 2025
Dec 15, 2025 SCHEDULE 13D/A Activist holder update, amended
Nov 5, 2025 8-K items 2.02, 5.07, 9.01 Results released; Shareholder vote · Current report Nov 4, 2025
Nov 5, 2025 10-Q Quarterly report Sep 30, 2025
Nov 4, 2025 8-K items 8.01, 9.01 Other event · Current report
Sep 19, 2025 ARS Annual report to shareholders Jun 30, 2025
Sep 19, 2025 DEFA14A Extra proxy material
Sep 19, 2025 DEF 14A Proxy statement Nov 4, 2025
Aug 27, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 27, 2025 10-K Annual report Jun 30, 2025
Jul 29, 2025 8-K items 8.01, 9.01 Other event · Current report
40 of 243 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton PAHC · research, not advice